Merck, Novo Nordisk spared from 1,500 suits over diabetes drug blamed for cancer

Novo Nordisk has been let off the hook in multiple lawsuits brought forth by diabetes patients in the US, alleging cancer links with some of Novo’s and also Merck’s diabetes treatments.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
By Jef Feeley, bloomberg

Consumers suing Merck & Co., Novo Nordisk A/S and other makers of diabetes drugs allegedly linked to pancreatic cancer are dropping their complaints, according to an email seen by Bloomberg.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading